Evaluation system for cell-permeable CYP3A4 inhibitory activity using 1α,25-dihydroxy-vitamin D₃-induced intestinal cell lines

References

• Achira, M., et al., 1999. Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4. AAPS pharmScience, 1 (4), 14–19.
   Google Scholar
• Ai, Z., et al., 2019. Effect of stereochemical configuration on the transport and metabolism of catechins from green tea across Caco-2 monolayers. Molecules, 24 (6), 1185.
   Web of Science ®Google Scholar
• Aiba, T., et al., 2005. The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180. Drug metabolism and pharmacokinetics, 20 (4), 268–274.
   PubMedGoogle Scholar
• De Gottardi, A., et al., 2004. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Digestive diseases and sciences, 49 (6), 982–989.
   PubMed Web of Science ®Google Scholar
• Dresser, G.K., Bailey, D.G., and Carruthers, S.G., 2000. Grapefruit juice-felodipine interaction in the elderly. Clinical pharmacology and therapeutics, 68 (1), 28–34.
   PubMed Web of Science ®Google Scholar
• Englund, G., et al., 2014. Cytochrome p450 inhibitory properties of common efflux transporter inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 42 (3), 441–447.
   PubMed Web of Science ®Google Scholar
• Fahmi, O.A., et al., 2008. A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro. Drug metabolism and disposition: the biological fate of chemicals, 36 (8), 1698–1708.
   PubMed Web of Science ®Google Scholar
• Fitzsimmons, M.E., and Collins, J.M., 1997. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Drug metabolism and disposition: the biological fate of chemicals, 25 (2), 256–266.
   PubMed Web of Science ®Google Scholar
• Gibbs, M.A., et al., 2000. Persistent inhibition of CYP3A4 by ketoconazole in modified Caco-2 cells. Pharmaceutical research, 17 (3), 299–305.
   PubMed Web of Science ®Google Scholar
• Gibbs, M.A., et al., 1999. Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression. Drug metabolism and disposition, 27 (2), 180–187.
   PubMed Web of Science ®Google Scholar
• Gnerre, C., et al., 2004. Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics, 14 (10), 635–645.
   PubMedGoogle Scholar
• Greenblatt, D.J., et al., 2003. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice. Clinical pharmacology and therapeutics, 74 (2), 121–129.
   PubMed Web of Science ®Google Scholar
• Guengerich, F.P., 1999. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annual review of pharmacology and toxicology, 39, 1–17.
   PubMed Web of Science ®Google Scholar
• Hong, J., et al., 2003. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochemical and biophysical research communications, 310 (1), 222–227.
   PubMed Web of Science ®Google Scholar
• Hou, X.L., et al., 2007. Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells. International journal of pharmaceutics, 337 (1–2), 169–177.
   PubMed Web of Science ®Google Scholar
• Kabeya, T., et al., 2018. Cyclic AMP signaling promotes the differentiation of human induced pluripotent stem cells into intestinal epithelial cells. Drug metabolism and disposition, 46 (10), 1411–1419.
   PubMed Web of Science ®Google Scholar
• Korobkova, E.A., 2015. Effect of natural polyphenols on CYP metabolism: implications for diseases. Chemical research in toxicology, 28 (7), 1359–1390.
   PubMed Web of Science ®Google Scholar
• Lown, K.S., Ghosh, M., and Watkins, P.B., 1998. Sequences of intestinal and hepatic cytochrome P450 3A4 cDNAs are identical. Drug metabolism and disposition: the biological fate of chemicals, 26 (2), 185–187.
   PubMed Web of Science ®Google Scholar
• Misaka, S., et al., 2013. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug metabolism and pharmacokinetics, 28 (3), 244–249.
   PubMed Web of Science ®Google Scholar
• Mizoi, K., et al., 2020b. Usefulness and limitations of mRNA measurement in HepaRG cells for evaluation of cytochrome P450 induction. Fundamental toxicological sciences, 7 (1), 9–14.
   Google Scholar
• Mizoi, K., et al. 2020a. Establishment of a primary human hepatocyte spheroid system for evaluating metabolic toxicity using dacarbazine under conditions of CYP1A2 induction. Drug metabolism and pharmacokinetics, 35 (2), 201–206.
   PubMed Web of Science ®Google Scholar
• Paine, M.F., Criss, A.B., and Watkins, P.B., 2004. Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties. Drug metabolism and disposition: the biological fate of chemicals, 32 (10), 1146–1153.
   PubMed Web of Science ®Google Scholar
• Piana, C., et al., 2008. Validation of reference genes for qPCR studies on Caco-2 cell differentiation. European journal of pharmaceutics and biopharmaceutics, 69 (3), 1187–1192.
   PubMed Web of Science ®Google Scholar
• Piver, B., et al. 2001. Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicology letters, 125 (1–3), 83–91.
   PubMed Web of Science ®Google Scholar
• Rendic, S., and Di Carlo, F.J., 1997. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug metabolism reviews, 29 (1–2), 413–580.
   PubMed Web of Science ®Google Scholar
• Roberts, A.G., et al., 2011. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4. Biochemistry, 50 (50), 10804–10818.
   PubMed Web of Science ®Google Scholar
• Sachar, M., Kelly, E.J., and Unadkat, J.D., 2019. Mechanisms of CYP3A induction during pregnancy: studies in HepaRG cells. The AAPS journal, 21 (3), 45.
   PubMed Web of Science ®Google Scholar
• Schmiedlin-Ren, P., et al., 1997. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. Molecular pharmacology, 51 (5), 741–754.
   PubMed Web of Science ®Google Scholar
• Shimada, T., et al., 2010. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. Chemical research in toxicology, 23 (12), 1921–1935.
   PubMed Web of Science ®Google Scholar
• Shimada, T., et al., 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of pharmacology and experimental therapeutics., 270 (1), 414–423.
   PubMed Web of Science ®Google Scholar
• Thummel, K.E., et al., 2001. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Molecular pharmacology, 60 (6), 1399–1406.
   PubMed Web of Science ®Google Scholar
• Tsujimoto, M., et al., 2009. The structure-activity correlation on the inhibitory effects of flavonoids on cytochrome P450 3A activity. Biological & pharmaceutical bulletin, 32 (4), 671–676.
   PubMed Web of Science ®Google Scholar
• von Moltke, L.L., et al., 2004. Interaction of triazolam and ketoconazole in P-glycoprotein-deficient mice. Drug metabolism and disposition: the biological fate of chemicals, 32 (8), 800–804.
   PubMed Web of Science ®Google Scholar
• Wienkers, L.C., and Heath, T.G., 2005. Predicting in vivo drug interactions from in vitro drug discovery data. Nature reviews. drug discovery, 4 (10), 825–833.
   PubMed Web of Science ®Google Scholar
• Zheng, X.E., et al., 2012. Human PXR-mediated induction of intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D3 function in human colon adenocarcinoma LS180 cells. Biochemical pharmacology, 84 (3), 391–401.
   PubMed Web of Science ®Google Scholar